Home › Companies › SCPHARMACEUTICALS INC. › 2023-2024
At SCPHARMACEUTICALS INC.'s shareholder meeting held June 11, 2024, in the 2023-2024 proxy season, 86 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 650 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory (non-binding) basis, the compensation of the Company's named… — FOR was 98% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: SCPHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 14, 2024.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and SCPHARMACEUTICALS INC.’s Form 8-K, filed June 14, 2024 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 11, 2024: 6 items on SCPHARMACEUTICALS INC.’s Form 8-K, filed June 14, 2024: 6 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024 2024-2025
Explore SCPHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are SCPHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 14, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Frederick Hudson | 17,097,871 | -- | -- | 2,338,614 | 6,434,859 | 88% | Not verified | — |
| Elect Director: Leonard D. Schaeffer | 15,762,635 | -- | -- | 3,673,850 | 6,434,859 | 81% | Not verified | — |
| Elect Director: Sara Bonstein | 16,177,596 | -- | -- | 3,258,889 | 6,434,859 | 83% | Not verified | — |
| 2. Ratification of the appointment of RSM US LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 | 25,822,386 | 19,825 | 29,133 | -- | 0 | 99.9% | Not verified | — |
| 3. Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers | 18,854,452 | 406,754 | 175,279 | -- | 6,434,859 | 98% | Not verified | — |
| 4. Approval of an amendment to the Second Amended and Restated Certificate of Incorporation to provide for the exculpation of officers from certain breaches of fiduciary duty to the extent permitted by the General Corporation Law of the State of Delaware | 14,269,318 | 3,298,424 | 1,868,743 | -- | 6,434,859 | 81% | Not verified | — |
Source: SCPHARMACEUTICALS INC., Form 8-K, filed with the SEC on June 14, 2024 — read the filing on EDGAR.
Each item below shows how the 86 asset managers that disclosed a SCPHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
Description as filed by funds: Election of Class I Directors: Frederick Hudson
SCPHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Frederick Hudson”): 17,097,871 for, 2,338,614 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 88% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 1,018,602 for, 1,299,584 withheld, 12,246 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Thrivent | 0 | 0 | 0 | 1,053,440 | Withhold |
| Vanguard | 622,296 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 174,796 | Withhold |
| BlackRock | 161,315 | 0 | 0 | 0 | For |
| Charles Schwab | 72,558 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 56,347 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 33,929 | Withhold |
| Lincoln Financial | 24,000 | 0 | 0 | 2,003 | Mixed |
| Equitable | 13,199 | 0 | 0 | 10,370 | Mixed |
| Fidelity | 23,515 | 0 | 0 | 0 | For |
| Global X | 14,884 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 12,246 | 0 | Abstain |
| Voya | 9,937 | 0 | 0 | 0 | For |
| Pacific Life | 9,143 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 5,725 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 0 | 0 | 0 | 5,632 | Withhold |
| DWS | 0 | 0 | 0 | 4,473 | Withhold |
| Principal | 0 | 0 | 0 | 3,378 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 3,244 | Withhold |
| Victory Capital | 0 | 0 | 0 | 2,971 | Withhold |
| Calvert | 0 | 0 | 0 | 2,385 | Withhold |
| State Street | 2,031 | 0 | 0 | 0 | For |
| Nationwide | 0 | 0 | 0 | 1,485 | Withhold |
| PENN SERIES FUNDS INC | 1,100 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 1,066 | Withhold |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
81% Majority: yes · of votes cast
Description as filed by funds: Election of Class I Directors: Leonard D. Schaeffer
SCPHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Leonard D. Schaeffer”): 15,762,635 for, 3,673,850 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 81% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 622,296 for, 1,690,121 withheld, 18,015 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Thrivent | 0 | 0 | 0 | 1,053,440 | Withhold |
| Vanguard | 622,296 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 174,796 | Withhold |
| BlackRock | 0 | 0 | 0 | 161,315 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 72,558 | Withhold |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 56,347 | Withhold |
| Dimensional | 0 | 0 | 0 | 33,929 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 26,003 | Withhold |
| Equitable | 0 | 0 | 0 | 23,569 | Withhold |
| Fidelity | 0 | 0 | 0 | 23,515 | Withhold |
| Global X | 0 | 0 | 0 | 14,884 | Withhold |
| John Hancock | 0 | 0 | 12,246 | 0 | Abstain |
| Voya | 0 | 0 | 0 | 9,937 | Withhold |
| Pacific Life | 0 | 0 | 0 | 9,143 | Withhold |
| Bridge Builder Trust | 0 | 0 | 5,725 | 0 | Abstain |
| Principal Exchange-Traded Funds | 0 | 0 | 0 | 5,632 | Withhold |
| DWS | 0 | 0 | 0 | 4,473 | Withhold |
| Principal | 0 | 0 | 0 | 3,378 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 3,244 | Withhold |
| Victory Capital | 0 | 0 | 0 | 2,971 | Withhold |
| Calvert | 0 | 0 | 0 | 2,385 | Withhold |
| State Street | 0 | 0 | 0 | 2,031 | Withhold |
| Nationwide | 0 | 0 | 0 | 1,485 | Withhold |
| PENN SERIES FUNDS INC | 0 | 0 | 0 | 1,100 | Withhold |
| ProShares | 0 | 0 | 0 | 1,066 | Withhold |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
83% Majority: yes · of votes cast
Description as filed by funds: Election of Class I Directors: Sara Bonstein
SCPHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Sara Bonstein”): 16,177,596 for, 3,258,889 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 83% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 694,749 for, 1,617,712 withheld, 17,971 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Thrivent | 0 | 0 | 0 | 1,053,440 | Withhold |
| Vanguard | 622,296 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 174,796 | Withhold |
| BlackRock | 0 | 0 | 0 | 161,315 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 72,558 | Withhold |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 56,347 | Withhold |
| Dimensional | 0 | 0 | 0 | 33,929 | Withhold |
| Lincoln Financial | 24,000 | 0 | 0 | 2,003 | Mixed |
| Equitable | 10,370 | 0 | 0 | 13,199 | Mixed |
| Fidelity | 23,515 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 0 | 14,884 | Withhold |
| John Hancock | 0 | 0 | 12,246 | 0 | Abstain |
| Voya | 9,937 | 0 | 0 | 0 | For |
| Pacific Life | 0 | 0 | 0 | 9,143 | Withhold |
| Bridge Builder Trust | 0 | 0 | 5,725 | 0 | Abstain |
| Principal Exchange-Traded Funds | 0 | 0 | 0 | 5,632 | Withhold |
| DWS | 0 | 0 | 0 | 4,473 | Withhold |
| Principal | 0 | 0 | 0 | 3,378 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 3,244 | Withhold |
| Victory Capital | 0 | 0 | 0 | 2,971 | Withhold |
| Calvert | 0 | 0 | 0 | 2,385 | Withhold |
| State Street | 2,031 | 0 | 0 | 0 | For |
| Nationwide | 0 | 0 | 0 | 1,485 | Withhold |
| PENN SERIES FUNDS INC | 1,100 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 1,066 | Withhold |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
81% Majority: yes · of votes cast
Description as filed by funds: To approve an amendment to the Second Amended and Restated Certificate of Incorporation to provide for the exculpation of officers from certain breaches of fiduciary duty to the extent permitted by the General Corporation Law of the State of Delaware.
SCPHARMACEUTICALS INC.’s own tally for this item (“4. Approval of an amendment to the Second Amended and Restated Certificate of Incorporation to provide for the exculpation of officers from certain breaches of fiduciary duty to the extent permitted by the General Corpor”): 14,269,318 for, 3,298,424 against, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 81% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 2,259,157 for, 71,275 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Thrivent | 1,053,440 | 0 | 0 | 0 | For |
| Vanguard | 622,296 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 174,796 | 0 | 0 | 0 | For |
| BlackRock | 161,315 | 0 | 0 | 0 | For |
| Charles Schwab | 72,558 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 56,347 | 0 | 0 | Against |
| Dimensional | 33,929 | 0 | 0 | 0 | For |
| Lincoln Financial | 26,003 | 0 | 0 | 0 | For |
| Equitable | 23,569 | 0 | 0 | 0 | For |
| Fidelity | 23,515 | 0 | 0 | 0 | For |
| Global X | 0 | 14,884 | 0 | 0 | Against |
| John Hancock | 12,246 | 0 | 0 | 0 | For |
| Voya | 9,937 | 0 | 0 | 0 | For |
| Pacific Life | 9,143 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 5,725 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 5,632 | 0 | 0 | 0 | For |
| DWS | 4,473 | 0 | 0 | 0 | For |
| Principal | 3,378 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 3,244 | 0 | 0 | 0 | For |
| Victory Capital | 2,971 | 0 | 0 | 0 | For |
| Calvert | 2,385 | 0 | 0 | 0 | For |
| State Street | 2,031 | 0 | 0 | 0 | For |
| Nationwide | 1,485 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,100 | 0 | 0 | 0 | For |
| ProShares | 1,066 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers.
SCPHARMACEUTICALS INC.’s own tally for this item (“3. Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers”): 18,854,452 for, 406,754 against, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Thrivent | 1,053,440 | 0 | 0 | 0 | For |
| Vanguard | 622,296 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 174,796 | 0 | 0 | 0 | For |
| BlackRock | 161,315 | 0 | 0 | 0 | For |
| Charles Schwab | 72,558 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 56,347 | 0 | 0 | Against |
| Dimensional | 33,929 | 0 | 0 | 0 | For |
| Lincoln Financial | 26,003 | 0 | 0 | 0 | For |
| Equitable | 23,569 | 0 | 0 | 0 | For |
| Fidelity | 23,515 | 0 | 0 | 0 | For |
| Global X | 14,884 | 0 | 0 | 0 | For |
| John Hancock | 12,246 | 0 | 0 | 0 | For |
| Voya | 9,937 | 0 | 0 | 0 | For |
| Pacific Life | 9,143 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 5,725 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 5,632 | 0 | 0 | 0 | For |
| DWS | 4,473 | 0 | 0 | 0 | For |
| Principal | 3,378 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 3,244 | 0 | 0 | 0 | For |
| Victory Capital | 2,971 | 0 | 0 | 0 | For |
| Calvert | 0 | 2,385 | 0 | 0 | Against |
| State Street | 2,031 | 0 | 0 | 0 | For |
| Nationwide | 1,485 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,100 | 0 | 0 | 0 | For |
| ProShares | 1,066 | 0 | 0 | 0 | For |
Fund voting reports, all 32 managers: 2,271,700 for, 58,732 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 5,559,528 | 0 | 0 | 0 | For |
| Rubric Capital Management LP | 1,695,205 | 0 | 0 | 0 | For |
| 5AM Venture Management, LLC | 1,200,647 | 0 | 0 | 0 | For |
| J. Goldman & Co LP | 1,118,645 | 0 | 0 | 0 | For |
| Thrivent | 1,072,277 | 0 | 0 | 0 | For |
| BlackRock | 393,887 | 0 | 0 | 0 | For |
| KING LUTHER CAPITAL MANAGEMENT CORP | 376,042 | 0 | 0 | 0 | For |
| State Street | 328,550 | 0 | 0 | 0 | For |
| RICE HALL JAMES & ASSOCIATES, LLC | 0 | 287,491 | 0 | 0 | Against |
| Citadel | 225,540 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 177,496 | 0 | 0 | 0 | For |
| KENNEDY CAPITAL MANAGEMENT LLC | 142,509 | 0 | 0 | 0 | For |
| Northern Trust | 132,623 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 115,904 | 0 | 0 | 0 | For |
| Charles Schwab | 72,558 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 30,605 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 24,443 | 0 | 0 | 0 | For |
| Vanguard | 23,710 | 0 | 0 | 0 | For |
| Dimensional | 20,758 | 0 | 0 | 0 | For |
| Mitsubishi UFJ Asset Management Co., Ltd. | 19,983 | 0 | 0 | 0 | For |
| Goldman Sachs | 15,157 | 0 | 0 | 0 | For |
| John Hancock | 12,301 | 0 | 0 | 0 | For |
| Invesco | 0 | 11,730 | 0 | 0 | Against |
| NEW YORK STATE COMMON RETIREMENT FUND | 11,535 | 0 | 0 | 0 | For |
| JPMorgan | 11,323 | 0 | 0 | 0 | For |
Institutional-manager reports, all 64 managers: 12,882,396 for, 304,625 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: To ratify the appointment of RSM US LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.
SCPHARMACEUTICALS INC.’s own tally for this item (“2. Ratification of the appointment of RSM US LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024”): 25,822,386 for, 19,825 against, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 32 asset managers below reported 2,330,432 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Thrivent | 1,053,440 | 0 | 0 | 0 | For |
| Vanguard | 622,296 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 174,796 | 0 | 0 | 0 | For |
| BlackRock | 161,315 | 0 | 0 | 0 | For |
| Charles Schwab | 72,558 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 56,347 | 0 | 0 | 0 | For |
| Dimensional | 33,929 | 0 | 0 | 0 | For |
| Lincoln Financial | 26,003 | 0 | 0 | 0 | For |
| Equitable | 23,569 | 0 | 0 | 0 | For |
| Fidelity | 23,515 | 0 | 0 | 0 | For |
| Global X | 14,884 | 0 | 0 | 0 | For |
| John Hancock | 12,246 | 0 | 0 | 0 | For |
| Voya | 9,937 | 0 | 0 | 0 | For |
| Pacific Life | 9,143 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 5,725 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 5,632 | 0 | 0 | 0 | For |
| DWS | 4,473 | 0 | 0 | 0 | For |
| Principal | 3,378 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 3,244 | 0 | 0 | 0 | For |
| Victory Capital | 2,971 | 0 | 0 | 0 | For |
| Calvert | 2,385 | 0 | 0 | 0 | For |
| State Street | 2,031 | 0 | 0 | 0 | For |
| Nationwide | 1,485 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,100 | 0 | 0 | 0 | For |
| ProShares | 1,066 | 0 | 0 | 0 | For |
Showing the 25 largest of 32 asset managers. All 32 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 36,054,409 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Thrivent | 2.92% |
| 2 | Vanguard | 1.73% |
| 3 | BRIDGEWAY FUNDS INC | 0.48% |
| 4 | BlackRock | 0.45% |
| 5 | Charles Schwab | 0.20% |
| 6 | CLEARWATER INVESTMENT TRUST | 0.16% |
| 7 | Dimensional | 0.09% |
| 8 | Lincoln Financial | 0.07% |
| 9 | Equitable | 0.07% |
| 10 | Fidelity | 0.07% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | ORBIMED ADVISORS LLC | 15.42% |
| 2 | Rubric Capital Management LP | 4.70% |
| 3 | 5AM Venture Management, LLC | 3.33% |
| 4 | J. Goldman & Co LP | 3.10% |
| 5 | Thrivent | 2.97% |
| 6 | BlackRock | 1.09% |
| 7 | KING LUTHER CAPITAL MANAGEMENT CORP | 1.04% |
| 8 | State Street | 0.91% |
| 9 | RICE HALL JAMES & ASSOCIATES, LLC | 0.80% |
| 10 | Citadel | 0.63% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| AIGH Capital Management LLC | 11.58% | 13G |
| Luther King Capital Management Corporation | 8.66% | 13G |
| BlackRock | 6.60% | 13F |
| Vanguard Group | 6.04% | 13F |
| Morgan Stanley | 4.64% | 13F |
| Dr. John D. Diekman | 2.72% | 13G |
| Citadel Advisors | 1.71% | 13F |
| State Street | 1.60% | 13F |
| Geode Capital | 1.50% | 13F |
| Northern Trust | 0.73% | 13F |
Percentages above are of 36,054,409 shares outstanding, as reported by SCPHARMACEUTICALS INC. on its Form 10-Q dated May 13, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from SCPHARMACEUTICALS INC.’s 10-Q dated May 13, 2024. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
SCPHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025.
proxyvotesnow.com, “SCPHARMACEUTICALS INC. 2024 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/scpharmaceuticals-inc/2024 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.